Medicine & Life Sciences
Mucopolysaccharidosis I
100%
Iduronidase
78%
Gene Editing
47%
GM1 Gangliosidosis
45%
Sandhoff Disease
40%
Mucopolysaccharidosis IV
26%
Galactosidases
24%
Enzymes
20%
Brain
19%
Glycosaminoglycans
18%
Mucopolysaccharidoses
17%
Lysosomal Storage Diseases
16%
Hexosaminidases
16%
G(M2) Ganglioside
15%
Genetic Association Studies
14%
Electrophoresis, Gel, Two-Dimensional
14%
Single Nucleotide Polymorphism
13%
Metabolomics
13%
Phenotype
13%
Transgenes
13%
Proteins
13%
Blood-Brain Barrier
13%
Genetic Therapy
13%
Lectins
12%
Central Nervous System
12%
Cardiovascular System
12%
Liver
11%
Computer Simulation
11%
Proteomics
11%
Injections
11%
Genome
11%
Clinical Trials
10%
Clustered Regularly Interspaced Short Palindromic Repeats
9%
Mutation
9%
Computational Biology
9%
Spleen
9%
Monoclonal Antibodies
9%
Complementary DNA
8%
GM2 Gangliosidosis
8%
Biomarkers
7%
Codon
6%
Iduronate Sulfatase
6%
Genes
6%
Zinc Finger Nucleases
6%
Guidelines
6%
Gangliosides
5%
Hydrolases
5%
Albumins
5%
Synaptic Transmission
5%
Hepatocytes
5%
Chemical Compounds
Metabolic
29%
Enzyme Activity
20%
Glycosaminoglycan
19%
Two Dimensional Polyacrylamide Gel Electrophoresis
14%
Complementary DNA
12%
Biological Marker
11%
Foam
11%
Safety
10%
Mutation
9%
Protein
8%
Metabolite
8%
Donor
8%
N-Acetylgalactosamine 4-Sulfate
6%
Ganglioside GM2
5%
Ganglioside
5%
Pharmacological Metabolism
5%